Patents by Inventor Michael A. Goode

Michael A. Goode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11013251
    Abstract: The invention provides a nutritional supplement and/or pharmaceutical composition for tableting comprising an embedded lubrication matrix. The embedded lubrication matrix comprises an oily liquid finely dispersed in an oil insoluble material. A method of lubricating a nutritional supplement or pharmaceutical composition for tableting using a matrix with embedded lubrication is also provided.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: May 25, 2021
    Assignee: PF Consumer Healthcare 1, LLC
    Inventors: Yong Dai, Alan M. Goldberg, Michael A. Goode, Raymond Alan Bartolucci, James O. Frazier
  • Publication number: 20190365802
    Abstract: This invention provides a nutritional supplement composition which is a vitamin mint that can be taken anytime or anywhere without water or other liquid which is usually required for swallowing a tablet. The present invention is a nutritional supplement composition which is a convenient, flavorful and enjoyable vitamin mint which can be ingested without water.
    Type: Application
    Filed: August 20, 2019
    Publication date: December 5, 2019
    Applicant: PF Consumer Healthcare 1 LLC
    Inventors: Michael A. Goode, Anne Rehne Volke
  • Publication number: 20170251711
    Abstract: The invention provides a nutritional supplement and/or pharmaceutical composition for tableting comprising an embedded lubrication matrix. The embedded lubrication matrix comprises an oily liquid finely dispersed in an oil insoluble material. A method of lubricating a nutritional supplement or pharmaceutical composition for tableting using a matrix with embedded lubrication is also provided.
    Type: Application
    Filed: May 22, 2017
    Publication date: September 7, 2017
    Applicant: Wyeth LLC
    Inventors: Yong Dai, Alan M. Goldberg, Michael A. Goode, Raymond Alan Bartolucci, James O. Frazier
  • Publication number: 20160199409
    Abstract: This invention provides a nutritional supplement composition which is a vitamin mint that can be taken anytime or anywhere without water or other liquid which is usually required for swallowing a tablet. The present invention is a nutritional supplement composition which is a convenient, flavorful and enjoyable vitamin mint which can be ingested without water.
    Type: Application
    Filed: January 13, 2016
    Publication date: July 14, 2016
    Applicant: Pfizer Inc.
    Inventors: Michael A. Goode, Anne Rehne Volke
  • Publication number: 20140342047
    Abstract: The invention provides a nutritional supplement and/or pharmaceutical composition for tableting comprising an embedded lubrication matrix. The embedded lubrication matrix comprises an oily liquid finely dispersed in an oil insoluble material. A method of lubricating a nutritional supplement or pharmaceutical composition for tableting using a matrix with embedded lubrication is also provided.
    Type: Application
    Filed: August 1, 2014
    Publication date: November 20, 2014
    Applicant: Wyeth LLC
    Inventors: Yong Dai, Alan M. Goldberg, Michael A. Goode, Raymond Alan Bartolucci, James O. Frazier
  • Publication number: 20080254119
    Abstract: The invention provides a nutritional supplement and/or pharmaceutical composition for tableting comprising an embedded lubrication matrix. The embedded lubrication matrix comprises an oily liquid finely dispersed in an oil insoluble material. A method of lubricating a nutritional supplement or pharmaceutical composition for tableting using a matrix with embedded lubrication is also provided.
    Type: Application
    Filed: April 16, 2007
    Publication date: October 16, 2008
    Applicant: Wyeth
    Inventors: Yong Dai, Alan M. Goldberg, Michael A. Goode, Raymond Alan Bartolucci, James O. Frazier
  • Patent number: 4886782
    Abstract: The circumsporozoite (CS) protein of Plasmodium falciparum has been analyzed to develop a new anti-sporozoite malarial vaccine. Localization of sites for T-cell recognition on this molecule is critical for vaccine design. By using an algorithm designed to predict T-cell sites and a large panel of H-2 congenic mice, a major nonrepetitive T-cell was located. When a synthetic peptide corresponding to this site was covalently linked to the major B-cell site on the molecule, an immunogen capable of eliciting a high titer antibody response was formed. This peptide sequence is capable of priming helper T-cells for a secondary response to the intact CS protein. This site represents the first helper T-cell site described for the CS molecule outside of the repetitive region, and is a major immunodominant T-site on the molecule. The approach described herein is useful in the rational design and construction of more efficacious vaccines.
    Type: Grant
    Filed: February 26, 1987
    Date of Patent: December 12, 1989
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael A. Good, Jay Berzofsky, Louis H. Miller
  • Patent number: D748240
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: January 26, 2016
    Assignee: Pfizer Inc.
    Inventor: Michael A. Goode
  • Patent number: D748241
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: January 26, 2016
    Assignee: Pfizer Inc.
    Inventor: Michael A. Goode
  • Patent number: D782646
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: March 28, 2017
    Assignee: Pfizer Inc.
    Inventor: Michael A. Goode
  • Patent number: D783799
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: April 11, 2017
    Assignee: Pfizer Inc.
    Inventor: Michael A. Goode
  • Patent number: D783800
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: April 11, 2017
    Assignee: Pfizer Inc.
    Inventor: Michael A. Goode
  • Patent number: D783801
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: April 11, 2017
    Assignee: Pfizer Inc.
    Inventor: Michael A. Goode